;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • EyeGate amends IPO

    EyeGate Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic Date announced: 2014-11-20 Type: IPO To be raised: Up to $11.4 million Shares: 1.4 million Price: $6-$8 Underwriter: Aegis Capital Overallotment: 214,286…

    Published on 11/24/2014
  • Aequus Pharmaceuticals completes venture financing

    Aequus Pharmaceuticals Inc., Vancouver, Beta.C. Business: Neurology, Drug delivery Date completed: 2014-11-20 Type: Venture financing Raised: C$4.2 million ($3.7 million) Placement Agents: Cormark Securities; Clarus …

    Published on 11/24/2014
  • Amicus Therapeutics completes follow-on

    Amicus Therapeutics Inc. (NASDAQ:FOLD), Cranbury, N.J. Business: Endocrine/Metabolic Date completed: 2014-11-18 Type: Follow-on Raised: $90.1 million Shares: 13.9 million Price: $6.50 Shares after offering: 93.1 million…

    Published on 11/24/2014
  • BeneVir completes venture financing

    BeneVir Biopharm Inc., Rockville, Md. Business: Cancer Date completed: 2014-11-19 Type: Venture financing Raised: Not disclosed Investor: HC2 Holdings Note: The amount raised is not disclosed.

    Published on 11/24/2014
  • BioNano Genomics completes venture financing

    BioNano Genomics Inc., San Diego, Calif. Business: Diagnostic, Genomics, Supply/Service Date completed: 2014-11-20 Type: Venture financing Raised: $53 million Investors: Legend Capital; Novartis Venture Funds; Federated…

    Published on 11/24/2014
  • C4X Discovery completes placing

    C4X Discovery Ltd. (LSE:C4XD), Manchester, U.K. Business: Computational chemistry/biology Date completed: 2014-10-23 Type: Placing Raised: 11 million ($17.2 million) Shares: 11 million Price: 100p Shares after offering:…

    Published on 11/24/2014
  • Flowonix Medical completes venture financing

    Flowonix Medical Inc., Mt. Olive, N.J. Business: Drug delivery Date completed: 2014-11-11 Type: Venture financing Raised: $20 million Investors: Elevage Capital Management LLC; Clarus Ventures; Hercules Technology …

    Published on 11/24/2014
  • Flowonix Medical completes venture financing

    Flowonix Medical Inc., Mt. Olive, N.J. Business: Drug delivery Date completed: 2014-11-11 Type: Venture financing Raised: $15 million Placement agent: Armentum Partners Investor: Hercules Technology Growth Capital Note:…

    Published on 11/24/2014
  • Galena Biopharma completes private placement

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. Business: Cancer Date completed: 2014-11-20 Type: Private placement Raised: $5 million Shares: 2.5 million Price: $2 Shares after offering: 124.6 million Investor: …

    Published on 11/24/2014
  • ImevaX completes venture financing

    ImevaX GmbH, Munich, Germany Business: Infectious Date completed: 2014-10-28 Type: Venture financing Raised: EUR7.5 million ($9.5 million) Investors: Wellington Partners; BioMedInvest; BioMedPartners; EMBL Ventures; …

    Published on 11/24/2014
  • Immune Pharmaceuticals completes follow-on

    Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP), Tarrytown, N.ZZZ. Business: Cancer, Neurology, Autoimmune Date completed: 2014-11-20 Type: Follow-on Raised: $8.6 million Units: 3.5 million Price: $2.50 (unit) …

    Published on 11/24/2014
  • Intellia Therapeutics completes venture financing

    Intellia Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics Date completed: 2014-11-18 Type: Venture financing Raised: $15 million Investors: Atlas Ventures; Novartis AG

    Published on 11/24/2014
  • Lexicon completes follow-on

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Business: Gastrointestinal, Autoimmune, Functional genomics Date completed: 2014-11-21 Type: Follow-on Raised: $50 million Shares: 49.8 million Price: $1.…

    Published on 11/24/2014
  • Lexicon completes private placement

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Business: Gastrointestinal, Autoimmune, Functional genomics Date completed: 2014-11-21 Type: Private placement Raised: $150 million Shares: 149.3 million …

    Published on 11/24/2014
  • Lexicon completes private placement of senior convertible notes

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Business: Gastrointestinal, Autoimmune, Functional genomics Date completed: 2014-11-21 Type: Private placement of senior convertible notes Raised: $80 …

    Published on 11/24/2014
  • Myos completes private placement of common stock and warrants

    Myos Corp. (NASDAQ:MYOS), Cedar Knolls, N.J. Business: Musculoskeletal, Endocrine/Metabolic, Nutraceuticals Date completed: 2014-11-18 Type: Private placement of common stock and warrants Raised: $1.8 million Shares: …

    Published on 11/24/2014
  • N30 Pharma completes venture financing

    N30 Pharmaceuticals LLC, Boulder, Colo. Business: Pulmonary, Inflammation Date completed: 2014-11-19 Type: Venture financing Raised: $30 million Placement agent: Cowen Investors: Wellington Management; RA Capital …

    Published on 11/24/2014
  • Neothetics completes IPO

    Neothetics Inc. (NASDAQ:NEOT), San Diego, Calif. Business: Ophthalmic, Endocrine/Metabolic Date completed: 2014-11-19 Type: IPO Raised: $65.1 million Shares: 4.7 million Price: $14 Shares after offering: 13.6 million …

    Published on 11/24/2014
  • NephroGenex completes debt financing

    NephroGenex Inc. (NASDAQ:NRX), Research Triangle Park, N.C. Business: Renal Date completed: 2014-11-20 Type: Debt financing Raised: $7 million Investor: East West Bank Note: The company drew down $7 million of a new $12…

    Published on 11/24/2014
  • Northwest Biotherapeutics completes private placement

    Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 2014-11-19 Type: Private placement Raised: $25 million Shares: 4.3 million Price: $5.79 Shares after offering: 66.5 million …

    Published on 11/24/2014
  • Oxis completes private placement of convertible debentures and warrants

    Oxis International Inc. (OTCBB:OXIS; Euronext:OXI), Beverly Hills, Calif. Business: Nutraceuticals, Autoimmune, Inflammation Date completed: 2014-11-10 Type: Private placement of convertible debentures and warrants …

    Published on 11/24/2014
  • Receptos completes follow-on

    Receptos Inc. (NASDAQ:RCPT), San Diego, Calif. Business: Autoimmune, Inflammation Date completed: 2014-11-18 Type: Follow-on Raised: $360 million Shares: 3.6 million Price: $100 Shares after offering: 31 million …

    Published on 11/24/2014
  • Reva Medical completes private placement of convertible notes

    Reva Medical Inc. (ASX:RVA), San Diego, Calif. Business: Cardiovascular, Diagnostic Date completed: 2014-11-20 Type: Private placement of convertible notes Raised: $25 million Shares outstanding prior: 33.5 million …

    Published on 11/24/2014
  • Rockwell Medical completes follow-on

    Rockwell Medical Inc. (NASDAQ:RMTI), Wixom, Mich. Business: Renal, Hematology Date completed: 2014-11-19 Type: Follow-on Raised: $58.5 million Shares: 6.5 million Price: $9 Shares after offering: 47.5 million …

    Published on 11/24/2014
  • Baird Capital financial update

    Baird Capital, Milwaukee, Wis. Business: Finance Date announced: 2014-11-18 Note: Baird Capital closed its fourth fund, Fund IV, at $185 million. The fund exceeded its initial target of $150 million. The fund invests in…

    Published on 11/24/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993